Sartorius Stedim Biotech SA (SDMHF)
203.75
+10.75
(+5.57%)
USD |
OTCM |
Apr 06, 16:00
Sartorius Stedim Biotech EPS Diluted (Quarterly) : 0.5658 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | -1.170 |
| Cellectis SA | -0.2621 |
| Transgene SA | -- |
| Adocia SA | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 54.94M |
| Revenue (Quarterly) | 898.79M |
| Total Expenses (Quarterly) | 843.73M |
| Enterprise Value | 22.42B |
| Gross Profit Margin (Quarterly) | 41.04% |
| Profit Margin (Quarterly) | 6.11% |
| Earnings Yield | 1.42% |
| Operating Earnings Yield | 2.97% |
| Normalized Earnings Yield | 1.696 |